42 related articles for article (PubMed ID: 19399691)
21. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
22. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
23. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
Kamps MP; Wright DD; Lu Q
Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
[TBL] [Abstract][Full Text] [Related]
24. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
[TBL] [Abstract][Full Text] [Related]
25. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
Knoepfler PS; Kamps MP
Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
[TBL] [Abstract][Full Text] [Related]
26. The role of E2A-PBX1 in leukemogenesis.
Aspland SE; Bendall HH; Murre C
Oncogene; 2001 Sep; 20(40):5708-17. PubMed ID: 11607820
[No Abstract] [Full Text] [Related]
27. Poor prognosis of B-cell acute lymphoblastic leukemia with TCF/PBX1 fusion gene and ovarian involvement at diagnosis: Two case reports and review of the literature.
Vinti L; Del Baldo G; Lodi M; Stocchi F; Cefalo MG; Pagliara D
Pediatr Blood Cancer; 2022 Jan; 69(1):e29299. PubMed ID: 34411424
[No Abstract] [Full Text] [Related]
28. The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia.
Yang M; Tang Y; Zhu P; Lu H; Wan X; Guo Q; Xiao L; Liu C; Guo L; Liu W; Yang Y
Ann Hematol; 2023 Dec; ():. PubMed ID: 38148344
[TBL] [Abstract][Full Text] [Related]
29. Relationship between the structure and function of the transcriptional regulator E2A.
Liang JJ; Peng H; Wang JJ; Liu XH; Ma L; Ni YR; Yang HJ; Zhang YQ; Ai WB; Wu JF
J Biol Res (Thessalon); 2021 Jul; 28(1):15. PubMed ID: 34271975
[TBL] [Abstract][Full Text] [Related]
30. Research progress of PBX1 in developmental and regenerative medicine.
Chen H; Yu Z; Niu Y; Wang L; Xu K; Liu J
Int J Med Sci; 2023; 20(2):225-231. PubMed ID: 36794159
[TBL] [Abstract][Full Text] [Related]
31. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications.
Kao TW; Chen HH; Lin J; Wang TL; Shen YA
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189085. PubMed ID: 38341110
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive overview of the role of PBX1 in mammalian kidneys.
Zou F; Liu M; Sui Y; Liu J
Front Mol Biosci; 2023; 10():1106370. PubMed ID: 37006624
[TBL] [Abstract][Full Text] [Related]
33. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
[TBL] [Abstract][Full Text] [Related]
34. E2A basic helix-loop-helix transcription factors in human leukemia.
LeBrun DP
Front Biosci; 2003 May; 8():s206-22. PubMed ID: 12700034
[TBL] [Abstract][Full Text] [Related]
35. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation.
Kamps MP
Curr Top Microbiol Immunol; 1997; 220():25-43. PubMed ID: 9103673
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
